Bacteria’s hidden weapon: toxins locked inside a capsule secured by a cork
New insights into the bacterial type VI secretion system could one day help to develop antibacterial and antifungal applications
The microbiome is home to an estimated 100 trillion bacteria, existing as a dense colony of many different strains and species. Similar to all organisms, bacteria must also compete with one another for space and resources, engaging in “warfare” by releasing toxins to kill competitors. One of the many weapons bacteria use in this inevitable fight is the type VI secretion system (T6SS), which delivers toxic effectors into their enemies. The groups of Stefan Raunser from the Max Planck Institute of Molecular Physiology in Dortmund and John Whitney from McMaster University in Canada, have now together uncovered the high-resolution 3D structure of such an effector from Pseudomonas protegens by cryo-electron microscopy. The effector protein, called RhsA, has a toxic component that sits unlocked and ready to be fired within a molecular cocoon sealed by a cork-like structure. Their findings will not only help in understanding how the T6SS machinery works, but will also promote the future development of antibacterial treatments and plant protection strategies.
3D structure of the Pseudomonas protegens RhsA effector. RhsA encapsulates its toxic effector domain (red). The cocoon is sealed by the cork-structure (yellow). Cleaving inside of RhsA occurs via the blue autoproteolysis domain.
MPI of Molecular Physiology
Model showing arming of the effector (blue) and the poison dart (green). Initially, the seal and the toxin are cleaved (scissors) from the rest of the protein which is then attached to the poison dart.
MPI of Molecular Physiology
The beneficial bacterium Pseudomonas protegens protects plants from fungi and bacteria. However, behind this seemingly selfless act lies a complex system by which the bacteria try to occupy a biological niche by eliminating their competitors. For this purpose, bacteria have developed a whole arsenal of poisons and a variety of injection systems to prepare them for battle.
Like a poison dart
One of the most widely-used injection machinery in Gram-negative bacteria is the type VI secretion system. When this machinery is activated, a nanotube is assembled in the cell interior, through which a poison dart with deadly toxic proteins on its tip is shot into a competitor. The 3D structure of one of these toxic proteins, the bacterial RhsA effector, has now been solved by the team of Stefan Raunser along with the team of John Whitney. The scientists found that the RhsA effector consists of three connecting pieces: the toxic weapon itself, a cocoon surrounding it, and a cork-like plug which seals the toxin encapsulating cocoon entirely.
Unlocking a bacterial weapon
“The cocoon protects the bacterium from its self-produced toxin”, Stefan Raunser says. “We already observed a very similar strategy in bacterial Tc toxins.” The scientists have shown that the effector protein itself cleaves the seal and the toxin from the rest of the protein, thereby unlocking the deadly weapon. However, the release of the toxic component is not yet possible since the seal keeps the cocoon secured. “We suspect that when the poison dart penetrates the enemy bacterium, mechanical force is generated to remove the cleaved seal, similar to when a champagne cork pops. This would ensure that the toxin is released in the right place at the right time” Stefan Raunser says.
In a series of earlier collaborative projects, the scientists have already gained a lot of knowledge about how the T6SS injection system works. They were able to reveal how effectors are transported inside the cell, how they are loaded on the poison dart and how the dart is then delivered into the host cell. “Our latest collaborative work now provides molecular insights into the arming process of Rhs effectors and its importance for toxin release. I am quite optimistic that our continued collaboration will uncover even more details of the T6SS machinery. This could one day allow for the engineering of bacteria with improved pathogen suppression capabilities useful for antibacterial and antifungal applications” John Whitney says.
Original publication
Other news from the department science
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
